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Abstract
Background: Glycogen Synthase Kinase 3 (GSK3) has been implicated in regulating chromosomal alignment and mitotic
progression but the physiological substrates mediating these GSK3-dependent effects have not been identified. Collapsin
Response Mediator Protein 4 (CRMP4) is a cytosolic phosphoprotein known to regulate cytoskeletal dynamics and is a
known physiological substrate of GSK3. In this study, we investigate the role of CRMP4 during mitosis.
Methodology and Principal Findings: Here we demonstrate that during mitosis CRMP4 phosphorylation is regulated in a
GSK3-dependent manner. We show that CRMP4 localizes to spindle microtubules during mitosis and loss of CRMP4 disrupts
chromosomal alignment and mitotic progression. The effect of CRMP4 on chromosomal alignment is dependent on
phosphorylation by GSK3 identifying CRMP4 as a critical GSK3 substrate during mitotic progression. We also provide
mechanistic data demonstrating that CRMP4 regulates spindle microtubules consistent with its known role in the regulation
of the microtubule cytoskeleton.
Conclusion and Significance: Our findings identify CRMP4 as a key physiological substrate of GSK3 in regulating
chromosomal alignment and mitotic progression through its effect on spindle microtubules.
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Introduction
Chromosomal alignment and segregation are important well-
controlled steps in mitosis. This process is largely regulated by the
mitotic spindle where microtubules and microtubule binding
proteins capture condensed chromosomes by their kinetochores
and direct them to the metaphase plate. Understanding the
molecular mechanisms responsible for regulating the process of
chromosomal alignment is important because failure to accurately
segregate chromosomes results in chromosome non-disjunction
and aneuploidy [1].
Glycogen Synthase Kinase 3 (GSK3) is a serine/threonine
kinase originally identified as a kinase that phosphorylates
glycogen synthase during glycogen metabolism. There are two
isoforms of GSK3, GSK3a and GSK3b, which are ubiquitously
expressed and constitutively active in cells. GSK3 is inactivated by
phosphorylation at its amino-terminus serine (serine 21 for a or
serine 9 for b) by several protein kinases such as protein kinase B
(PKB, also called Akt), MAPK-activated protein kinase-1 (MAP-
KAP-K1, also called RSK) and p70 ribosomal S6 kinase-1 [2].
GSK3 has been implicated in a diverse range of cellular functions
including the regulation of mitotic spindle dynamics and
chromosomal alignment [2,3,4,5].
Reports that GSK3b plays a role in regulating microtubule
dynamics during interphase provide evidence that GSK3 may
regulate spindle microtubules [6]. GSK3b can phosphorylate
microtubule-associated proteins (MAPs) such as Tau, MAP1B and
MAP2C resulting in decreased microtubule stability [6,7,8].
Repressing GSK3 function with GSK3 inhibitors or GSK3b
RNAi alters spindle morphology, increases defects in chromosom-
al alignment, and subsequently delays mitotic progression [3,5].
Although the importance of GSK3 as a mitotic kinase has been
recognized, the physiological substrates that mediate the GSK3-
dependent effects during mitosis have yet to be identified.
Collapsin Response Mediator Proteins (CRMPs) are cytosolic
phosphoproteins that are highly expressed in the nervous system
during development [9,10,11,12,13,14]. The CRMP family is
composed of five family members (CRMP1–5) in vertebrates
[9,11,15,16,17]. Each CRMP allele produces two transcripts that
differ in their amino terminal domains producing a long (L-
CRMP) and short (S-CRMP) isoforms that have been alternatively
referred to as ‘a’ and ‘b’ isoforms [18,19,20,21]. The CRMPs have
been implicated in regulating axon path finding and neurite
outgrowth [9,13,15,18,20,22,23]. Although the CRMPs have not
been directly implicated in mitosis, previous studies have shown
that CRMP1 and CRMP2 localize to the mitotic spindle
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tubules, while CRMP4 has been shown to promote F-actin
bundling [20,27,28]. Further, CRMP4, but not other CRMP
family members, binds to RhoA, an important regulator of cell
cycle progression and cytokinesis [20,29,30]. These observations
suggest that CRMPs, particularly CRMP4, may play a role in
regulating microtubule dynamics during mitosis.
In this study, we investigate the role of CRMP4, a known
physiological substrate of GSK3, during mitosis [31,32]. We
identify CRMP4 as a GSK3 substrate that regulates chromosomal
alignment during mitosis.
Results
CRMP4 localizes to spindle microtubules during mitosis
PreviousstudieshaveshownthatCRMP1andCRMP2localizeto
the mitotic spindle [24,25,26]. Although CRMP4 has been shown to
bind to tubulin and F-actin, CRMP4 localization throughout the
mitotic cycle has not been investigated [27,28]. To investigate
CRMP4 localization during mitosis we double stained HeLa cells
with CRMP4 and a-tubulin antibodies. We established the
specificity of the CRMP4 antibody by immunostaining HeLa cells
that were depleted of CRMP4 and observed a reduction in the
immunoreactivity at the mitotic spindle (Fig. 1). Throughout the
different stages of mitosis we observed CRMP4 co-localizing with
microtubules (Fig. 1). During interphase, CRMP4 was primarily
associated with microtubules located in the perinuclear region of the
cell but was also associated along actin stress fibers. Further, we
observed CRMP4 localization to actin structures such as the
cleavage furrow and the cortex. As the cells entered mitosis and
progressed from prometaphase to metaphase, CRMP4 localized
along spindle microtubules. CRMP4 remained localized with
microtubules throughout anaphase and telophase, and strongly co-
localized with microtubules associated with the mid-body.
CRMP4 influences chromosomal alignment and mitotic
progression
The presence of CRMP4 along the mitotic spindle raises the
possibility that CRMP4 regulates mitotic microtubules. To
investigate the role of CRMP4 during mitosis we used RNA
interference to knockdown CRMP4 protein expression in HeLa
cells and followed the mitotic progression of these cells following
synchronization with a double thymidine block. Introduction of
CRMP4 siRNA robustly inhibited CRMP4 protein expression
while a control siRNA had no effect (Fig. 2A). To examine
chromosomal alignment, we fixed and stained the cells with
Hoechst 33342 to visualize DNA 9 hours following the second
thymidine block when the majority of cells were in metaphase. We
frequently observed CRMP4 siRNA-transfected mitotic cells with
abnormal metaphase plates that were characterized by at least one
misaligned chromosome (Fig. 2B). CRMP4 knockdown resulted in
a significant increase in the percentage of cells with abnormal
metaphase (Fig. 2C). We confirmed that the increase in abnormal
metaphase could be attributed to the targeted repression of
CRMP4 by rescuing the phenotype with an siRNA-resistant wild
type rat CRMP4 construct (L-CRMP4-WT-V5) (Fig. 2C). These
results demonstrate that CRMP4 plays an important role in the
proper alignment of chromosomes during mitosis.
A similar abnormal metaphase phenotype has been reported as a
result of GSK3 inhibition [3,5]. Consistent with previous reports, we
find that approximately 40% of cells treated with the GSK3 inhibitor
SB-216763 exhibited misaligned chromosomes [3,5], very similar to
the severity of effects observed with CRMP4 loss of function (Fig. 2C).
In addition, a delay in mitotic entry and exit has also been described
with GSK inhibition and has been attributed to an increase in time
taken for cells to align their chromosomes and progress from
prophase to metaphase [5], thus we investigated if CRMP4
knockdown would affect the rate of mitotic progression. We
transfected HeLa cells with a fluorescently tagged mcherry Histone
H3 and either control (Fig. 3A and Video S1) or CRMP4 siRNA
(Fig. 3B and Video S2) and visualized mitotic progression by time-
lapse microscopy. 48 hours following transfection, we measured the
time from nuclear envelope breakdown (NEB) to anaphase onset.
The average time taken for control siRNA treated cells to progress
through NEB to anaphase was 38 minutes, while CRMP4 siRNA
treated cells took an average of 47 minutes (Fig. 3C) indicating that
CRMP4 regulates the rate of mitotic progression. Although the
phenotype we observed with CRMP4 protein knockdown was equal
in severity to that seen with GSK3 inhibition (Fig. 2C), cells depleted
of CRMP4 protein eventually aligned all their chromosomes and
progressed through mitosis. This finding suggests that CRMP4
regulates accurate chromosomal alignment, but in its absence,
compensatory mechanisms are activated to ensure that the cell does
not initiate anaphase with misaligned chromosomes.
Consistent with previous reports we found that the release of
synchronized HeLa cells into SB-216763 resulted in an observable
delay in mitotic progression by flow cytometry (Fig. S1) [33]. We
did not detect a similar delay in mitotic progression in CRMP4
siRNA treated cells by flow cytometry, likely because hourly
collection of cells fails to detect short mitotic delays (Fig. 3C). The
severe effect of GSK3 inhibition on mitotic progression compared
to CRMP4 knockdown suggests that additional GSK3 substrates
affect mitotic progression.
CRMP4 depletion yields monopolar syntelic attachments
and reduces cold stable microtubules
It has been previously demonstrated that GSK3 inhibitor-
treated cells delay chromosomal alignment largely due to their
inability to perfectly bi-orient all their chromosomes [33]. More
specifically, monopolar syntelic attachments predominate in
GSK3 inhibitor-treated cells [33]. To determine if a similar
phenotype was observed following CRMP4 depletion, we
transfected HeLa cells with CRMP4 siRNA and immunostained
for a-tubulin and the kinetochore protein BubR1. Both GSK3
inhibition and CRMP4 depletion resulted in the presence of
monopolar syntelic attachments in HeLa cells, where both sister
kinetochores were attached to the same spindle pole (Fig. 4). Thus,
both GSK3 inhibition and CRMP4 depletion affected the ability
of a cell to perfectly bi-orient all of its chromosomes.
The presence of monopolar syntelic attachments, and the
increase in chromosomal misalignment following CRMP4 deple-
tion suggest that spindle microtubule stability is affected. To assess
spindle microtubule stability in CRMP4 depleted cells, we
performed a cold stability assay, which disintegrates mitotic
spindle structures over time except for spindle microtubules that
are stably attached to kinetochores [34,35]. While CRMP4
depletion or GSK3 inhibition had no effect on the average
tubulin intensity at the mitotic spindle at 0 minutes exposure
(Fig. 5A), we observed a significant reduction in cold stable
microtubules following a 10 minute exposure to ice cold media
(Fig. 5B). These findings indicate that both GSK3 and CRMP4
regulate spindle microtubule attachment to kinetochores.
CRMP4 is phosphorylated in a GSK3-dependent manner
during mitosis
Previous studies have identified CRMP4 as a physiological
substrate of GSK3 [31,32]. Following an initial priming event that
GSK3 and Chromosome Alignment
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specificity tyrosine phosphorylation regulated kinase 2 (DYRK2), L-
CRMP4 is sequentially phosphorylated by GSK3b on residues
Ser631, Thr627 and Thr622 [31]. We generated a phospho-specific
antibody recognizing pThr622 of L-CRMP4 (pThr509 of S-
CRMP4) [31] to detect CRMP4 that has been primed and fully
phosphorylated by GSK3. To investigate CRMP4 phosphorylation
throughout mitosis we synchronized HeLa cells using a double
thymidine block, collected the cells at different time intervals, and
immunoblotted with phospho-CRMP4 antibody. Lysates from
synchronized cells showed an increase in CRMP4 phosphorylation
from 7 hours to 11 hours following release from the second block
(Fig. 6A). This time interval corresponds to when the majority of
synchronized HeLa cells are undergoing mitosis (Fig. S1).
Furthermore, as the synchronized cells progressed through mitosis
and returned to interphase, the levels of phosphorylated CRMP4
decreased to similar levels seen in unsynchronized cells. The
phospho-CRMP4 doublet that appears corresponds to distinct
phospho-species of the long isoform of CRMP4 (Fig. S2A and S2B).
The increasein phosphorylated CRMP4 was alsoobserved inHeLa
cellsblockedwith nocodazole for16 hours (Fig.6CandFig.S2A).A
rat CRMP4 triple alanine substitution mutant (L-CRMP4-AAA-
V5) for the three carboxy terminal phospho-residues targeted by
GSK3b (Thr622, Thr627, Ser631) fails to undergo phosphorylation
in response to nocodazole establishing the specificity of the antibody
for phospho-CRMP4 (Fig. S2C).
Figure 1. CRMP4 localizes with spindle microtubules during mitosis. Immunofluorescence detection of CRMP4, a-tubulin, and DNA in
mitotic HeLa cells. HeLa cells were permeabilized with a cytosolic extraction buffer prior to fixation with 4% PFA. CRMP4 associates with microtubules
throughout mitosis. Immunofluorescence detection of CRMP4 was markedly reduced in HeLa cells transfected with CRMP4 siRNA. Bar, 10 um.
doi:10.1371/journal.pone.0014345.g001
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PLoS ONE | www.plosone.org 4 December 2010 | Volume 5 | Issue 12 | e14345To investigate if GSK3 is the kinase responsible for CRMP4
phosphorylation during mitosis, we synchronized HeLa cells with
a double thymidine block and released them into thymidine-free
media for 7.5 hours followed by a 90-minute incubation with a
GSK3 inhibitor. Two GSK3 inhibitors were used at concentra-
tions previously shown to inhibit GSK3 activity: SB-216763
(10 uM) or CT-99021 (2 uM) [3,5,36]. SB-216763 and CT-99021
both attenuated CRMP4 phosphorylation following cellular
synchronization and release with a double thymidine block or
with nocodazole (Fig. 6B and 6C). Although CRMP4 phosphor-
ylation was reduced in the presence of GSK3 inhibitors, the
phospho-signal was not completely abrogated raising the possibil-
Figure 3. siRNA-mediated knockdown of CRMP4 leads to a delay in mitotic progression. HeLa cells transfected with a fluorescently
tagged mcherry Histone H3 plasmid and either control or CRMP4 siRNA were analyzed by time-lapse microscopy. (A) Images from a time-lapse movie
showing a control cell that undergoes normal mitosis. (B) Images from a time-lapse movie showing a CRMP4 siRNA treated cell that delays anaphase
onset until the misaligned chromosome (arrow) aligns to the metaphasic plate. Time intervals are indicated in hours and minutes (0:00), where 0:00
corresponds to nuclear envelope breakdown (NEB). Bar, 10 um. (C) Scatter dot plot measuring the time interval from NEB to anaphase onset in
control and CRMP4 siRNA treated groups for 71 cells and 157 cells, respectively. CRMP4 siRNA treated cells delayed anaphase onset until all their
chromosomes were aligned to the metaphasic plate (***p,0.0001, Student’s t test compared to control siRNA).
doi:10.1371/journal.pone.0014345.g003
Figure 2. siRNA-mediated knockdown of CRMP4 leads to chromosomal misalignment. (A) HeLa cells transfected with CRMP4 siRNA,
control siRNA or treated with SB-216763 (10 uM) were immunoblotted with a CRMP4 antibody. CRMP4 siRNA transfection results in a reduction of
CRMP4 protein expression. (B) Synchronized HeLa cells were stained with Hoechst 33342 to visualize DNA. HeLa cells with misaligned chromosomes
(arrows) were scored as abnormal metaphase. Only cells in metaphase were scored. Representative images of HeLa cells with normal and abnormal
metaphase plates are shown. Bar, 10 um. (C) HeLa cells were transfected with either CRMP4 siRNA or control siRNA and were synchronized by double
thymidine block. HeLa cells were released into thymidine-free culture medium and fixed 9 hours later, when a large proportion of cells were in
metaphase. siRNA-mediated knockdown of CRMP4 resulted in an increase in the percentage of cells with abnormal metaphase (n=3, **p,0.01
Student’s t test compared to control siRNA). Co-transfection of HeLa cells with CRMP4 siRNA and a CRMP4 siRNA-resistant wild type rat L-CRMP4
construct (L-CRMP4-WT-V5) rescued the abnormal metaphase phenotype (n=3, **p,0.01, Student’s t test compared to CRMP4 siRNA; n=3, ns=non
significant p.0.05, Student’s t test compared to control siRNA). For experiments with the GSK3 inhibitor, SB-216763 (10 uM) was added 7.5 hours
following release into thymidine-free media and fixed 90 minutes later. Inhibition of GSK3 with SB-216763 resulted in an increase in the percentage of
abnormal metaphase cells (n=3, **p,0.01, Student’s t test compared to DMSO). n=3 refers to 3 independent experiments where at least 100 cells
were scored per experiment.
doi:10.1371/journal.pone.0014345.g002
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during mitosis.
To determine if other CRMP family members may be similarly
regulated, we examined the phosphorylation profile of CRMP1
and CRMP2, known GSK3 substrates, during mitosis [37].
Following cellular synchronization and release, we did not observe
any changes in threonine phosphorylation levels of CRMP1
(Fig. 6D) or CRMP2 phosphorylation at their GSK3 sites (Fig. 6E
and 6F). This suggests that although several CRMPs localize to the
mitotic spindle, CRMP4 may be specifically regulated by GSK3
during mitosis.
Chromosomal alignment during mitosis is phospho-
CRMP4-dependent
To localize phosphorylated CRMP4 in mitotic HeLa cells, we
immunostained dividing cells with phospho-CRMP4 antibody.
We established the specificity of the phospho-CRMP4 antibody by
immunostaining HeLa cells that were depleted of CRMP4 or
exposed to the GSK3 inhibitor SB-216763 and observed a
reduction in the pCRMP4 signal compared to control cells (Fig. 7).
Phosphorylated CRMP4 localized to both the cortex adjacent to
the spindle poles and to the spindle microtubules in metaphase
(Fig. 7). During anaphase and telophase, phosphorylated CRMP4
also localized to microtubules and to the cortex and cleavage
furrow located between the two dividing cells (Fig. 7). The
phospho-CRMP4 localization pattern is consistent with previous
reports that have shown GSK3 localization to the spindle
microtubules of mitotic HeLa cells [3]. Additionally, inactivated
phosphorylated GSK3 was concentrated at the centrosomes and
not along the spindle microtubules [3]. This localization pattern
provides indirect evidence that GSK3 associated with the spindle
microtubules is active.
To determine the importance of CRMP4 phosphorylation in
chromosomal alignment, we depleted endogenous CRMP4
protein using CRMP4 siRNA, and assessed whether a CRMP4
mutant that is not phosphorylated by GSK3b, L-CRMP4-AAA-
V5, could rescue the chromosomal misalignment phenotype. As
shown previously (Fig. 2C) rat L-CRMP4-WT-V5 rescues the
chromosomal misalignment phenotype in CRMP4-depleted cells;
however rat L-CRMP4-AAA-V5 fails to mediate rescue (Fig. 8).
This result demonstrates that CRMP4 phosphorylation is
necessary for proper chromosomal alignment during mitosis.
CRMP4 regulates spindle morphology
CRMP proteins are known to affect microtubule polymerization
raising the possibility that the role of phospho-CRMP4 may be to
regulate spindle microtubules. To investigate if phosphorylation
altered the ability of CRMP4 to associate with spindle microtu-
bules, we transfected HeLa cells with either L-CRMP4-WT-V5 or
L-CRMP4-AAA-V5 and immunostained for V5, a-tubulin and
DNA. Only wild type CRMP4 localized to the spindle
microtubules during metaphase, while the CRMP4 phospho-
mutant was observed throughout the cytoplasm (Fig. 9A) indicat-
ing that an important role for CRMP4 phosphorylation is to
localize CRMP4 to the spindle microtubules. To further
investigate the role of GSK3-dependent phosphorylation of
CRMP4 during mitosis, we treated HeLa cells with SB-216763
for 90 minutes and immunostained for CRMP4. We observed a
significant reduction of CRMP4 signal at the spindle microtubules
in SB-216763 treated HeLa cells compared to DMSO treated cells
(Fig. 9B and 9C). This finding is consistent with our data showing
that CRMP4 phosphorylation was reduced in the presence of
GSK3 inhibitors (Fig. 6B and 6C) but was not completely
abrogated.
Figure 4. CRMP4 depletion yields monopolar syntelic attachments. HeLa cells transfected with either control siRNA or CRMP4 siRNA for
48 hours, or treated with SB-216763 (10 uM) for 90 minutes were immunostained for a-tubulin (red), BubR1 (green) and DNA. Boxes outline either
normal microtubule-kinetochore attachment (top panel) or abnormal monopolar syntelic attachments (middle and bottom panels). Bar, 10 um.
doi:10.1371/journal.pone.0014345.g004
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morphology by transfecting HeLa cells with control or CRMP4
siRNA, fixing and immunostaining for a-tubulin. We performed
a morphometric analysis of the mitotic spindle by measuring
spindle length (pole to pole distance) and spindle width 9 hours
following release from a double thymidine block (Fig. 10A–10C),
as described previously with GSK3 inhibitors [33]. While siRNA-
mediated CRMP4 knockdown had no effect on spindle width
(Fig. 10C), we did observe a significant decrease in the pole to
pole distance compared to control treated cells (Fig. 10A and
10B). In CRMP4 siRNA-treated cells, L-CRMP4-WT-V5 but
not L-CRMP4-AAA-V5 rescued the spindle morphology
phenotype (Fig. 10A and 10B). This finding and the inability
of L-CRMP4-AAA-V5 to localize to spindle microtubules
(Fig. 9A) indicate that phosphorylated CRMP4 regulates spindle
morphology.
Discussion
Identification of CRMP4 as a regulator of mitotic
chromosomal alignment
Herein, we identify CRMP4 as a regulator of chromosomal
alignment during mitosis. We show that CRMP4 localizes to
spindle microtubules and demonstrate that CRMP4 loss of
function leads to defects in chromosomal alignment during mitosis
and delays in mitotic progression. We provide evidence that
CRMP4 is phosphorylated during mitosis in a GSK3-dependent
manner and demonstrate that CRMP4 phosphorylation by GSK3
regulates chromosomal alignment. Further, we show that CRMP4
loss of function yields monopolar syntelic attachments, reduces
cold stable microtubules, and alters spindle morphology. These
findings identify CRMP4 as a downstream regulator of GSK3-
dependent chromosomal alignment during mitosis.
Figure 5. CRMP4 depletion reduces cold stable microtubules. (A) HeLa cells transfected with either control siRNA or CRMP4 siRNA for
48 hours, or treated with SB-216763 (10 uM) for 90 minutes, were immunostained for a-tubulin (red) and DNA (blue). Bar, 5 um. Quantification of
average tubulin intensity at the mitotic spindle (n=3, ns=non significant p.0.05, one sample t test compared to control siRNA.) (B) HeLa cells
transfected with either control siRNA or CRMP4 siRNA for 48 hours, or treated with SB-216763 (10 uM) for 90 minutes, were incubated with ice cold
media for 10 minutes and immunostained for a-tubulin (red) and DNA (blue). Bar, 5 um. Quantification of average tubulin intensity at the mitotic
spindle following incubation with ice cold media for 10 mins. Both CRMP4 depletion (n=3, **p,0.01, one sample t test compared to control siRNA)
and incubation with SB-216763 (n=3, *p,0.05, one sample t test compared to control siRNA) resulted in a reduction in the average tubulin intensity
at the mitotic spindle. n=3 refers to 3 independent experiments where at least 19 cells were analyzed in each experiment.
doi:10.1371/journal.pone.0014345.g005
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alignment
The proteins that regulate microtubules during mitosis have not
been fully elucidated and our findings indicate that CRMP4 plays
such a role. CRMP1–4 bind to tubulin and CRMP1, 2 and 4
localize to the mitotic spindle [25,27]; however our data
demonstrating that the phosphorylation status of CRMP4 at its
GSK3 sites, but not CRMP1 or CRMP2, is regulated through the
mitotic cycle suggests that CRMP4 plays a unique role
downstream of GSK3 during mitosis. These observations raise
the possibility that CRMP1 and CRMP2 recruitment to the
mitotic spindle is regulated through a GSK3-independent
mechanism.
We demonstrate that CRMP4 localizes along spindle microtu-
bules in HeLa cells, and that CRMP4 depletion results in
chromosomal misalignment, mitotic delay, monopolar syntelic
attachments, a reduction in cold stable microtubules and a
decrease in spindle length. These findings provide evidence for an
important role for CRMP4 in organizing microtubules during
mitosis. Moreover, since microtubule dynamics are the major
determinants of metaphase spindle length, CRMP4 may have a
role in regulating microtubule dynamics [38]. Specifically, the
decrease in spindle length observed with CRMP4 depletion
suggests that CRMP4 may be involved with microtubule
stabilization since RNAi-depletion of proteins that promote
microtubule stabilization such EB1, Minispindles [Dis1/
XMAP215/TOG], and Mast/Orbit [CLASP] result in a shorten
metaphasic spindle [38]. In contrast, RNAi-depletion of proteins
that promote microtubule depolymerization such as Kinesin-8 and
Kinesin-13 result in a longer metaphasic spindle [38].
Figure 6. GSK3-dependent phosphorylation of CRMP4 during mitosis. (A) HeLa cells were synchronized by double thymidine block,
released into thymidine-free media and collected at different time intervals (number indicates hours post-release). Lysates were immunoblotted for
pCRMP4 and total CRMP4. CRMP4 is phosphorylated throughout mitotic progression and is dephosphorylated as the cells complete mitosis. We
observed that the majority of synchronized HeLa cells were in metaphase between 9–10 hours following release from the second thymidine block. By
12 hours, the majority of cells had completed mitosis. (B) HeLa cells were synchronized by double thymidine block, released into thymidine-free
media for 7.5 hours, and were incubated with either SB-216763 (10 uM) or CT-99021 (2 uM) for 90 minutes. Immunoblot of lysates with a pCRMP4 or
CRMP4 antibody showed that GSK3 inhibition with either SB-216763 or CT-99021 reduced the amount of pCRMP4 compared to DMSO treatment. (C)
HeLa cells were synchronized with nocodazole (1 uM) for 14.5 hours after which either SB-216763 (10 uM) or CT-99021 (2 uM) was added for 90
minutes. Immunoblot of lysates with a pCRMP4 or CRMP4 antibody show that GSK3 inhibition with either SB-216763 or CT-99021 reduced the
amount of pCRMP4 compared to DMSO treatment. (D) HeLa cells were transfected with L-CRMP1-V5 and either blocked with nocodazole for 16 hours
or treated with calyculin for 30 mins. L-CRMP1-V5 was immunoprecipitated from lysates and immunoblotted with a pThreonine antibody. CRMP1
phospho-threonine levels did not increase following nocodazole treatment, while calyculin treatment did increase phospho-threonine levels. (E) HeLa
cells were transfected with S-CRMP2-V5 and either blocked with nocodazole for 16 hours or treated with calyculin for 30 mins. S-CRMP2-V5 was
immunoprecipitated from lysates and immunoblotted with a pCRMP2 (pThr509/514) antibody. Phospho-CRMP2 levels did not increase following
nocodazole treatment, while calyculin treatment did increase phospho-CRMP2 levels. Input lysates were immunoblotted for pCRMP4 and CRMP4. (F)
Lysates from HeLa cells synchronized by double thymidine block were immunoblotted for pCRMP4, CRMP4, pCRMP2 (pThr509/514) and GAPDH.
Endogenous phospho-CRMP2 levels were unchanged throughout mitosis but increased with calyculin treatment.
doi:10.1371/journal.pone.0014345.g006
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microtubules at the mitotic spindle, rescues chromosomal
misalignment and the altered spindle morphology phenotype seen
in CRMP4-depleted cells. We generated a rat CRMP4 triple
glutamic acid substitution mutant (L-CRMP4-EEE-V5) for the
three carboxy terminal phospho-residues targeted by GSK3b
(Thr622, Thr627, Ser631) and find that it does not rescue the
misalignment phenotype observed with GSK3 inhibition (data not
Figure 7. Phosphorylated CRMP4 localizes with the mitotic apparatus. Immunofluorescence detection of pCRMP4, a-tubulin, and DNA in
mitotic HeLa cells. Phosphorylated CRMP4 accumulates both at the cortex adjacent to the spindle poles and spindle microtubules during metaphase.
Immunofluorescence detection of pCRMP4 is reduced in HeLa cells treated with the GSK3 inhibitor SB-216763 (10 uM) for 90 mins or transfected with
CRMP4 siRNA. Bar, 10 um.
doi:10.1371/journal.pone.0014345.g007
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does not function as a phospho-mimetic based on published results
demonstrating that an S-D mutation on a CRMP2 and CRMP4
priming residue (S522) does not mimic phosphorylation [31].
These findings support a model in which CRMP4 phosphorylation
at its GSK3 sites plays an important role in regulating spindle
microtubules during mitosis.
Our findings that CRMP4 depletion reduces cold stable
microtubules and yields monopolar syntelic attachments suggest
that CRMP4 is involved in the regulation of stable microtubule-
kinetochore attachments. However, the observation that CRMP4
depleted cells have an organized metaphasic plate and eventually
progress through mitosis with all their chromosomes aligned
indicates that stable microtubule-kinetochore attachments do
occur. Therefore the unstable microtubule-kinetochore attach-
ment phenotype we observed is most likely a transient one,
whereby compensatory mechanisms, such as Aurora B kinase
activation, can eliminate microtubule-kinetochore attachments
that do not generate tension and thereby ensure that the cell does
not progress through mitosis with misaligned chromosomes
[39,40,41,42].
CRMP4 can also promote an actin-based phenotype. Overex-
pression of CRMP4 results in the extension of filopodia and
neurite branches in neurons [20]. Similarly, CRMP4 can bundle
F-actin filaments in B35 neuroblastoma cells [28]. The ability of
CRMP4 to modulate the actin cytoskeleton raises the possibility
that CRMP4 plays an additional role in regulating actomyosin-
based events during mitosis. Interestingly, we do observe
localization of pT622 CRMP4 at the cortex during anaphase
and telophase in areas that have been associated with actin
structures, such as the cleavage furrow. However, the role of
CRMP4 in modulating these actin-based events during mitosis
remains to be investigated.
The role of CRMP4 phosphorylation during mitosis
The ability of L-CRMP4-WT-V5 but not L-CRMP4-AAA-V5
to rescue the chromosomal misalignment phenotype and the
altered spindle morphology phenotype resulting from CRMP4 loss
of function indicates that the function of CRMP4 in mitosis is
highly dependent on its phosphorylation status. Transient
phosphorylation/dephosphorylation of proteins is often critical
for the recruitment and release of binding partners. This raises the
possibility that CRMP4 may also regulate the complement of
proteins associated with the microtubule machinery over the
course of the mitotic cycle. CRMP4 binds to RhoA in a phospho-
dependent fashion and this interaction is disrupted by CRMP4
phosphorylation by GSK3b [20,43]. An interesting possibility is
that CRMP4 may recruit RhoA to the microtubule machinery and
that CRMP4 phosphorylation may result in the local release of
RhoA for binding to the microtubule machinery during the
mitotic cycle. Further, the ability of CRMP4 to bundle F-actin and
its localization to the cleavage furrow suggests that the role of
CRMP4 during mitosis may not be limited to regulating spindle
microtubules.
GSK3 as a regulator of chromosomal alignment and
mitotic progression
Previous studies have reported that GSK3 inhibition results in a
delay in mitotic exit, and this phenotype has been largely
attributed to chromosomal alignment defects [3,5]. Our finding
that CRMP4 loss of function results in a delay in mitotic
progression is consistent with our hypothesis that GSK3 regulates
chromosomal alignment through CRMP4. However, the more
severe effects observed with GSK3 inhibition on mitotic
progression and spindle morphology suggests that, in addition to
CRMP4, there are other downstream effectors of GSK3 that are
involved with these processes.
Several other MAPs identified as GSK3 substrates are
candidates for regulating additional aspects of microtubule
dynamics during mitosis. GSK3 can phosphorylate Tau, MAP1B
and MAP2C, all of which result in a decreased ability to stabilize
microtubules [7,8,44]. Both CLIP-associated protein (CLASP) 2
and Adenomatous Polposis Coli (APC) are phosphorylated by
GSK3, which alters their ability to bind and stabilize the distal end
of microtubules [45,46,47]. Further, mutations that eliminate the
microtubule-binding domain of APC result in defective chromo-
somal segregation [46].
GSK3 can also target substrates other than MAPs that likely
contribute to GSK3-dependent effects on mitotic progression.
There is evidence that GSK3 positively regulates protein levels of
Aurora A, a mitotic kinase that has been implicated in the
centrosome cycle, spindle assembly, chromosomal segregation and
mitotic progression [48,49,50]. Further, GSK3 can phosphorylate
cyclin dependent kinases (Cdks), which control cell cycle
progression in response to mitogenic signals [51,52,53]. Therefore,
the delay in mitotic progression seen with GSK3 inhibition may
not be fully attributed to defects in chromosomal alignment but
rather the dysregulation of mitotic complexes that control cell
cycle progression.
Materials and Methods
Cell Culture
HeLa cells (ATCC; catalogue number CCL-2) were grown in
DMEM (Invitrogen, Burlington, Ontario) supplemented with 10%
FBS (HyClone, Logan, UT) and were maintained in 5% CO2 at
37uC. Cells were synchronized using a double thymidine block as
previously described [54]. In brief, HeLa cells (,45% confluency)
Figure 8. Chromosomal alignment during mitosis is phospho-
CRMP4-dependent. Overexpression of L-CRMP4-WT-V5 rescued the
abnormal metaphase phenotype observed with CRMP4 knockdown
(n=3, one way ANOVA, post-hoc Bonferroni test, ***p,0.001 compared
CRMP4 siRNA) while overexpression of the CRMP4 mutant L-CRMP4-
AAA-V5 fails to rescue the phenotype (n=3, one way ANOVA, post-hoc
Bonferonni test, ns=non significant p.0.05 compared to CRMP4
siRNA). n=3 refers to 3 independent experiments where at least 100
cells were scored per experiment.
doi:10.1371/journal.pone.0014345.g008
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12–13 hours, and grown in 2.5 mM thymidine for 12–13 hours.
The cells were released from the second block and fixed 9 hours
later for immunofluorescence microscopy when most of the cells
were in metaphase. For immunoblotting, HeLa cells were
collected at different time intervals following release from the
second block. In some experiments, HeLa cells were blocked with
1 uM nocodazole for 16 hours.
Plasmids and antibodies
The L-CRMP4-WT-V5 construct was described previously
[20]. L-CRMP4-AAA-V5 was generated using site-directed
mutagenesis (Thr622, Thr627, Ser631) (Stratagene, La Jolla,
CA). CRMP4 antibody to the antigen YDGPVFDLTTTPK (as
per [55]) and phosphospecific CRMP4 antibody to the antigen
FDLTT(pT)PKGGTPAGC (where pT is phosphothreonine) were
generously provided by Biogen Idec (Cambridge, MA). Antiserum
was affinity purified on an antigen-Sepharose column or was
affinity purified by depleting antibodies that recognize unpho-
sphorylated CRMP4 on a non-phosphorylated peptide column
followed by selecting phospho-specific antibodies on a phospho-
peptide antigen column. Other antibodies that were used: mouse
a-tubulin (Sigma-Aldrich, Oakville, ON), sheep anti-tubulin
(Cytoskeleton, Denver, CO), mouse BubR1 (BD Bioscience,
MD), mouse and rabbit V5 (Sigma-Aldrich), mouse GAPDH
(ABCAM, Cambridge, MA), rabbit phospho-Threonine (Sigma-
Figure 9. CRMP4 localization to the mitotic spindle is phospho-dependent. (A) HeLa cells were transfected with either L-CRMP4-WT-V5 or L-
CRMP4-AAA-V5. Immunofluorescence was used to detect V5, a-tubulin, and DNA in HeLa cells in metaphase. HeLa cells were permeabilized with a
cytosolic extraction buffer prior to fixation. L-CRMP4-WT-V5 localizes along the spindle microtubules while L-CRMP4-AAA-V5 does not. Bar, 10 um. (B)
HeLa cells were incubated with either 10 uM SB-216763 or DMSO for 90 minutes prior to fixation and immunostaining for CRMP4. Bar, 10 um. (C)
Quantification of CRMP4 intensity at the mitotic spindle shows a decrease in CRMP4 intensity in SB-216763 treated HeLa cells (n=3, *p,0.05,
Student’s t test compared to DMSO). n=3 refers to 3 independent experiments where at least 20 cells were analyzed per experiment.
doi:10.1371/journal.pone.0014345.g009
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provided by Dr. Calum Sutherland, Neurosciences Institute,
University of Dundee). The sheep phospho-CRMP2 (pT509/514)
antibody recognizes CRMP2 phosphorylated at its Thr509 and
Thr514, which are known GSK3 sites [31]. The following
secondary antibodies were used: goat anti-rabbit Alexa Fluor
488, goat anti-rabbit Alexa Fluor 568, goat anti-sheep Alexa Fluor
546, goat anti-human Alexa Fluor 647, goat anti-mouse Alexa
Fluor 647 (Invitrogen); goat anti-rabbit-HRP, goat anti-mouse-
HRP and goat anti-sheep-HRP (Sigma-Aldrich); goat anti-rabbit
IRDye 800 CW and goat anti-mouse IRDye 800 CW (LI-COR
Biosciences).
Pharmacological inhibitors
GSK3 inhibitors were used at the following concentrations:
10 uM SB-216763 (Sigma-Aldrich) and 2 uM CT-99021 (gener-
ously provided by Dr. Rodolfo Marquez, School of Life Sciences,
University of Dundee). For inhibitor experiments, the drugs were
Figure 10. siRNA-mediated knockdown of CRMP4 alters spindle morphology. (A) HeLa cells were transfected with either control or CRMP4
siRNA, and for rescue experiments were co-transfected with either L-CRMP4-WT-V5 or L-CRMP4-AAA-V5. In some experiments, HeLa cells were
treated with SB-216763 (10 um) for 90 mins. HeLa cells were permeabilized with a cytosolic extraction buffer prior to fixation with 4% PFA and
immunofluorescence detection of a-tubulin and DNA. Bar, 10 um. (B) Bar graph plotting pole to pole distance. HeLa cells transfected with CRMP4
siRNA had a shorter pole to pole distance (n=3, **p=0.0059, Student’s t test compared to control siRNA). Co-transfection with a L-CRMP4-WT-V5
construct rescued the shorter pole to pole distance phenotype (n=3, **p=0.0069, Student’s t test compared to CRMP4 siRNA) while a L-CRMP4-AAA-
V5 construct did not rescue (n=3, ns=non significant p.0.05, Student’s t test compared to CRMP4 siRNA). HeLa cells treated with SB-216763 (10 uM)
for 90 mins resulted in a shorter pole to pole distance (n=3, ***p,0.0001, Student’s t test compared to control siRNA; n=3, *p=0.0322, Student’s t
test compared to CRMP4 siRNA). (C) Bar graph plotting spindle width. HeLa cells transfected with either control siRNA, CRMP4 siRNA or treated with
SB-216763 did not show any differences in spindle width (n=3, ns=non significant p.0.05, Student’s t test compared to control siRNA). n=3 refers
to 3 independent experiments where at least 20 cells were analyzed per experiment.
doi:10.1371/journal.pone.0014345.g010
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thymidine block. Control treatments with solvent (DMSO) were
performed in parallel.
RNAi
Fluorescently tagged siRNA duplexes were designed to
knockdown human CRMP4 (both long ‘‘L’’ and short ‘‘S’’
isoforms) protein expression: sense 59 Alexa 488 GUG UUG AUG
ACG UAC GUU ATT 39, antisense 59 UAA CGU ACG UCA
UCA ACA CTT 39 (Invitrogen). CRMP4 siRNA was transfected
into HeLa cells using LipofectAMINE 2000 according to the
manufacturer’s instructions (Invitrogen). Control cells were
transfected with non-targeting control siRNA (Dharmacon,
Colorado, USA). HeLa cells were incubated with the transfection
mixture for 5 hours after which the media was replaced with fresh
growth medium.
Flow Cytometry
HeLa cells were transfected with CRMP4 siRNA and
synchronized by double thymidine block. HeLa cells were
collected at different time intervals after the second thymidine
block by trypsinizing the cells off the culture dish and fixing them
in ice-cold ethanol. HeLa cells were resuspended in propidium
iodide and analyzed using a FACScan at the McGill Flow
Cytometry Facility.
Immunoblot
HeLa cells were washed twice with ice cold PBS and lysed in
complete HEPES RIPA buffer (20 mM HEPES, 150 mM NaCl,
0.5% sodium deoxycholate, 0.1% SDS, 1% Triton X-100, 1 mM
Na3VO4, 5 mM NaF, 16protease inhibitors (Roche Diagnostics,
Laval, Quebec), 100 nM Calyculin A (Cell Signaling Technology,
Danvers, MA)). For experiments requiring plasmid transfection,
HeLa cell were grown to subconfluence and transfected with
Effectene according to manufacturer’s instructions (Qiagen,
Mississauga, ON). Lysates were separated by SDS-PAGE and
immunoblotted with phospho-CRMP4, CRMP4 and GAPDH
antibodies.
Immunoprecipitation
Transfected lysates were precleared with protein A/G-agarose
(Santa Cruz Biotechnology, Santa Cruz, CA) and subjected to
immunoprecipitation with V5-agarose (Sigma-Aldrich). After
washing three times with ice-cold lysis buffer, bound protein was
eluted with SDS and immunoblotted with anti-V5, phospho-
CRMP4, phospho-CRMP2 (pT509/514) or phospho-Threonine
antibodies. Briefly, either L-CRMP1-V5 or S-CRMP2-V5 was
immunoprecipitated with V5-agarose and immunoblotted with a
phospho-Threonine antibody or phospho-CRMP2 (pT509/514),
respectively. In another experiment, either L-CRMP4-WT-V5 or
L-CRMP4-AAA-V5 was immunoprecipitated with V5-agarose
and immunoblotted with phospho-CRMP4 antibody.
Immunofluorescence
HeLa cells were briefly washed in extraction buffer (Microtu-
bule Stabilization Buffer (MTSB): 100 mM PIPES pH 6.8, 1 mM
EGTA, 5 mM MgCl2), incubated with MTSB/0.05% Triton X-
100 for 2 minutes at room temperature, and fixed with 2%
paraformaldehyde (PFA) /0.02% Triton X-100/0.05 mM Taxol
in MTSB for 1 hour at room temperature. HeLa cells were
incubated with Image-iT FX signal enhancer (Invitrogen) for 30
minutes at room temperature and blocked in 5% BSA/0.2%
Triton X-100 in PBS for 30 minutes at room temperature.
Primary antibodies were diluted in 0.5% BSA in PBS for 3 hours
at room temperature. Secondary antibodies were diluted in 0.5%
BSA in PBS for 1 hour at room temperature. Actin was visualized
with an Alexa Fluor 568 phalloidin (Invitrogen) and DNA was
stained using DAPI (Invitrogen) or Hoechst 33342 (Invitrogen).
Cover slips were mounted using PermaFluor (Thermo Scientific,
Rockford, IL) and images were acquired with a Zeiss Axiovert 200
using a 636or 1006oil objective.
Chromosome Alignment Scoring
HeLa cells were transfected with CRMP4 siRNA or control
siRNA, synchronized by double thymidine block and fixed 9 hours
following the second block in 4% PFA/20% sucrose in PBS for 30
minutes at room temperature. In rescue experiments, L-CRMP4-
WT-V5 or L-CRMP4-AAA-V5 was co-transfected with the
siRNA duplexes. In some experiments, the GSK3 inhibitor SB-
216763 was added to the cells 7.5 hours following the second
thymidine block for 90 minutes. HeLa cells were permeabilized
with 0.2% Triton X-100 in PBS for 4 minutes and blocked with
5% BSA in PBS for 30 minutes. HeLa cells were incubated with a
rabbit anti-V5 antibody followed by a goat anti-rabbit AlexaFluor
568. DNA was visualized with Hoechst 33342. Coverslips were
mounted using Fluoromount-G (SouthernBiotech, Birmingham,
AL). CRMP4 siRNA-transfected cells were identified by virtue of
the fluorescent tag and only cells in metaphase were scored. HeLa
cells with at least one misaligned chromosome were scored as
abnormal metaphase. At least 100 cells were scored per
experiment.
Live Time-Lapse Microscopy
For time-lapse analysis, HeLa cells were cultured on 35 mm
glass bottom dishes (MatTek Co., Ashland, MA) and transfected
with an mcherry Histone H3 construct (generously provided by
Dr. Paul Maddox, Universite ´ de Montreal) and either control or
CRMP4 siRNA. Microscopy was performed on Zeiss Axiovert
200 using a 206objective equipped with an automated stage and
an environmental control chamber, which maintained the cells at
37uC and 5% CO2. Nuclear envelope breakdown (NEB) was
defined as the point when prophase chromatin lost a smooth,
linear periphery, and the time of anaphase onset was defined to be
the first frame where coordinated pole wards movement was
observed [33].
Morphometric analysis of mitotic spindles
For pole to pole distance measurements, tubulin fluorescence
intensities were measured from one end of the cell to the other end
along the spindle axis using ImageJ, and when plotted as a
function of spindle position, the tubulin intensity gave two peaks
corresponding to the spindle poles (Fig. S3) [33]. For spindle width
measurements, the two lateral edges of the mitotic spindle were
identified by tubulin fluorescence and the distance between them
was measured using ImageJ. For pole to pole distance and spindle
width measurements, at least 3 independent experiments were
performed with at least 20 cells per condition measured in each
experiment.
Cold Stability Assay
Cold stability assay was performed as previously described [35].
Briefly, HeLa cells were incubated with ice cold media for 10
minutes before fixation and immunostaining for a-tubulin. For
quantification of average tubulin intensity at the mitotic spindle,
images were acquired at the same exposure and mitotic spindles
were traced using ImageJ. For average tubulin intensity measure-
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were performed with at least 19 cells per condition measured in
each experiment.
Supporting Information
Figure S1 GSK3 inhibition delays mitotic exit. Flow cytometry
graphs of double thymidine block synchronized HeLa cells
transfected with CRMP4 siRNA or transfection reagent alone.
HeLa cells were collected at different time intervals following
release into thymidine-free media (upper and middle panels) or
media containing SB-216763 (10 uM) (lower panels). Knockdown
of CRMP4 protein expression did not delay mitotic entry or exit,
while treatment with SB-216763 resulted in a delay in mitotic
progression. M2=2n peak, M4=4n peak.
Found at: doi:10.1371/journal.pone.0014345.s001 (0.51 MB TIF)
Figure S2 Phosphorylation of L-CRMP4 during mitosis. (A) An
increase in L-CRMP4 phosphorylation at the Thr622 residue was
observed with pT622 CRMP4 antibody in nocodazole blocked
HeLa cell lysates. The phospho doublet band was also detected
with a CRMP4 antibody, however the upper band was faint
compared to the lower band. Overexpression of L-CRMP4-V5 or
S-CRMP4-V5 in HeLa cells reveals that the majority of
endogenous CRMP4 is L-CRMP4. (B) Lysates from HeLa cells
transfected with either control or CRMP4 siRNA, and synchro-
nized with a double thymidine block, were probed with either
pT622 CRMP4, CRMP4 or GAPDH. (C) HeLa cells were
transfected with pcDNA V5, L-CRMP4 WT-V5, or L-CRMP4
AAA-V5 and were blocked with nocodazole (1 uM) for 16 hours.
V5 was immunoprecipitated from the lysates and immunoblotted
with pCRMP4 or V5 antibodies. The pCRMP4 antibody did not
recognize L-CRMP4 AAA-V5.
Found at: doi:10.1371/journal.pone.0014345.s002 (0.38 MB TIF)
Figure S3 Representative line scan of pole to pole distance
measurements. For pole to pole distance measurements, tubulin
fluorescence intensities were measured from one end of the cell to
the other end along the spindle axis using ImageJ, and when
plotted as a function of spindle position, the tubulin intensity gave
two peaks corresponding to the spindle poles.
Found at: doi:10.1371/journal.pone.0014345.s003 (0.10 MB TIF)
Video S1 Mitotic progression in control siRNA transfected
HeLa cells. HeLa cell transfected with control siRNA, and
mcherry H3 histone to label chromosomes.
Found at: doi:10.1371/journal.pone.0014345.s004 (0.12 MB
MOV)
Video S2 Mitotic progression in CRMP4 siRNA transfected
HeLa cells. HeLa cell transfected with CRMP4 siRNA and
mcherry H3 histone delays mitotic progression.
Found at: doi:10.1371/journal.pone.0014345.s005 (0.11 MB
MOV)
Acknowledgments
The authors would like to thank Dr. Rodolfo Marquez (School of Life
Sciences, University of Dundee) and Dr. Calum Sutherland (Neurosciences
Institute, University of Dundee) for generously providing CT-99021 and
phospho-CRMP2 (pT509/514) antibody, respectively. The authors would
also like to thank Dr. Paul Maddox for generously providing the mcherry
Histone H3 construct (Universite ´ de Montreal) and for comments and
suggestions on this manuscript. The authors would also like to thank Dr.
Madeline Pool for comments and suggestions on this manuscript.
Author Contributions
Conceived and designed the experiments: SOT BD AF CM. Performed
the experiments: SOT BD. Analyzed the data: SOT AF CM. Wrote the
paper: SOT AF CM.
References
1. Decordier I, Cundari E, Kirsch-Volders M (2008) Survival of aneuploid,
micronucleated and/or polyploid cells: crosstalk between ploidy control and
apoptosis. Mutat Res 651: 30–39.
2. Frame S, Cohen P (2001) GSK3 takes centre stage more than 20 years after its
discovery. Biochem J 359: 1–16.
3. Wakefield J, Stephens D, Tavare J (2003) A role for glycogen synthase kinase-3
in mitotic spindle dynamics and chromosome alignment. Journal of Cell Science
116: 637–646.
4. Cohen P, Goedert M (2004) GSK3 inhibitors: development and therapeutic
potential. Nature reviews Drug discovery 3: 479–487.
5. Tighe A, Ray-Sinha A, Staples O, Taylor S (2007) GSK-3 inhibitors induce
chromosome instability. BMC Cell Biol 8: 34.
6. Ciani L, Krylova O, Smalley MJ, Dale TC, Salinas PC (2004) A divergent
canonical WNT-signaling pathway regulates microtubule dynamics: dishevelled
signals locally to stabilize microtubules. The Journal of Cell Biology 164:
243–253.
7. Wang JZ, Wu Q, Smith A, Grundke-Iqbal I, Iqbal K (1998) Tau is
phosphorylated by GSK-3 at several sites found in Alzheimer disease and its
biological activity markedly inhibited only after it is prephosphorylated by A-
kinase. FEBS Lett 436: 28–34.
8. Goold RG, Owen R, Gordon-Weeks PR (1999) Glycogen synthase kinase 3beta
phosphorylation of microtubule-associated protein 1B regulates the stability of
microtubules in growth cones. Journal of Cell Science 112(Pt 19): 3373–3384.
9. Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM (1995) Collapsin-
induced growth cone collapse mediated by an intracellular protein related to
UNC-33. Nature 376: 509–514.
10. Wang LH, Strittmatter SM (1996) A family of rat CRMP genes is differentially
expressed in the nervous system. J Neurosci 16: 6197–6207.
11. Gaetano C, Matsuo T, Thiele CJ (1997) Identification and characterization of a
retinoic acid-regulated human homologue of the unc-33-like phosphoprotein
gene (hUlip) from neuroblastoma cells. J Biol Chem 272: 12195–12201.
12. Byk T, Ozon S, Sobel A (1998) The Ulip family phosphoproteins—common and
specific properties. Eur J Biochem 254: 14–24.
13. Quinn CC, Gray GE, Hockfield S (1999) A family of proteins implicated in axon
guidance and outgrowth. J Neurobiol 41: 158–164.
14. Quach TT, Duchemin A-M, Rogemond V, Aguera M, Honnorat J, et al. (2004)
Involvement of collapsin response mediator proteins in the neurite extension
induced by neurotrophins in dorsal root ganglion neurons. Mol Cell Neurosci
25: 433–443.
15. Minturn JE, Fryer HJ, Geschwind DH, Hockfield S (1995) TOAD-64, a gene
expressed early in neuronal differentiation in the rat, is related to unc-33, a C.
elegans gene involved in axon outgrowth. J Neurosci 15: 6757–6766.
16. Byk T, Dobransky T, Cifuentes-Diaz C, Sobel A (1996) Identification and
molecular characterization of Unc-33-like phosphoprotein (Ulip), a putative
mammalian homolog of the axonal guidance-associated unc-33 gene product.
J Neurosci 16: 688–701.
17. Inatome R, Tsujimura T, Hitomi T, Mitsui N, Hermann P, et al. (2000)
Identification of CRAM, a novel unc-33 gene family protein that associates with
CRMP3 and protein-tyrosine kinase(s) in the developing rat brain. J Biol Chem
275: 27291–27302.
18. Quinn CC, Chen E, Kinjo TG, Kelly G, Bell AW, et al. (2003) TUC-4b, a novel
TUC family variant, regulates neurite outgrowth and associates with vesicles in
the growth cone. Journal of Neuroscience 23: 2815–2823.
19. Yuasa-Kawada J, Suzuki R, Kano F, Ohkawara T, Murata M, et al. (2003)
Axonal morphogenesis controlled by antagonistic roles of two CRMP subtypes
in microtubule organization. Eur J Neurosci 17: 2329–2343.
20. Alabed YZ, Pool M, Ong Tone S, Fournier AE (2007) Identification of CRMP4
as a convergent regulator of axon outgrowth inhibition. Journal of Neuroscience
27: 1702–1711.
21. Pan S, Chao Y, Chen H, Hung P, Lin P, et al. (2009) Long form collapsin
response mediator protein-1 (LCRMP-1) expression is associated with clinical
outcome and lymph node metastasis in non-small cell lung cancer patients. Lung
Cancer.
22. Hedgecock EM, Culotti JG, Thomson JN, Perkins LA (1985) Axonal guidance
mutants of Caenorhabditis elegans identified by filling sensory neurons with
fluorescein dyes. Dev Biol 111: 158–170.
23. Yoshimura T, Arimura N, Kawano Y, Kawabata S, Wang S, et al. (2005) Ras
regulates neuronal polarity via the PI3-kinase/Akt/GSK-3b/CRMP-2 pathway.
Biochemical and Biophysical Research Communications. pp 7.
24. Gu Y, Ihara Y (2000) Evidence that collapsin response mediator protein-2 is
involved in the dynamics of microtubules. J Biol Chem 275: 17917–17920.
25. Shih JY, Yang SC, Hong TM, Yuan A, Chen JJ, et al. (2001) Collapsin response
mediator protein-1 and the invasion and metastasis of cancer cells. J Natl Cancer
Inst 93: 1392–1400.
GSK3 and Chromosome Alignment
PLoS ONE | www.plosone.org 14 December 2010 | Volume 5 | Issue 12 | e1434526. Arimura N, Me ´nager C, Kawano Y, Yoshimura T, Kawabata S, et al. (2005)
Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Mol
Cell Biol 25: 9973–9984.
27. Fukata Y, Itoh TJ, Kimura T, Me ´nager C, Nishimura T, et al. (2002) CRMP-2
binds to tubulin heterodimers to promote microtubule assembly. Nat Cell Biol 4:
583–591.
28. Rosslenbroich V, Dai L, Baader SL, Noegel AA, Gieselmann V, et al. (2005)
Collapsin response mediator protein-4 regulates F-actin bundling. Experimental
Cell Research 310: 434–444.
29. Glotzer M (2001) Animal cell cytokinesis. Annu Rev Cell Dev Biol 17: 351–386.
30. Narumiya S, Yasuda S (2006) Rho GTPases in animal cell mitosis. Current
Opinion in Cell Biology 18: 199–205.
31. Cole AR, Knebel A, Morrice NA, Robertson LA, Irving AJ, et al. (2004) GSK-3
phosphorylation of the Alzheimer epitope within collapsin response mediator
proteins regulates axon elongation in primary neurons. J Biol Chem 279:
50176–50180.
32. Cole AR, Causeret F, Yadirgi G, Hastie CJ, McLauchlan H, et al. (2006)
Distinct priming kinases contribute to differential regulation of collapsin
response mediator proteins by glycogen synthase kinase-3 in vivo. J Biol Chem
281: 16591–16598.
33. Tighe A, Ray-Sinha A, Staples OD, Taylor SS (2007) GSK-3 inhibitors induce
chromosome instability. BMC Cell Biol 8: 34.
34. Lampson MA, Kapoor TM (2005) The human mitotic checkpoint protein
BubR1 regulates chromosome-spindle attachments. Nat Cell Biol 7: 93–98.
35. Jeffery JM, Urquhart AJ, Subramaniam VN, Parton RG, Khanna KK (2010)
Centrobin regulates the assembly of functional mitotic spindles. Oncogene 29:
2649–2658.
36. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, et al. (2007) The selectivity of
protein kinase inhibitors: a further update. Biochem J 408: 297–315.
37. Cole AR, Causeret F, Yadirgi G, Hastie CJ, McLauchlan H, et al. (2006)
Distinct priming kinases contribute to differential regulation of collapsin
response mediator proteins by glycogen synthase kinase-3 in vivo. J Biol Chem
281: 16591–16598.
38. Goshima G, Wollman R, Stuurman N, Scholey JM, Vale RD (2005) Length
control of the metaphase spindle. Curr Biol 15: 1979–1988.
39. Dewar H, Tanaka K, Nasmyth K, Tanaka TU (2004) Tension between two
kinetochores suffices for their bi-orientation on the mitotic spindle. Nature 428:
93–97.
40. Lampson MA, Renduchitala K, Khodjakov A, Kapoor TM (2004) Correcting
improper chromosome-spindle attachments during cell division. Nat Cell Biol 6:
232–237.
41. Maure J-F, Kitamura E, Tanaka TU (2007) Mps1 kinase promotes sister-
kinetochore bi-orientation by a tension-dependent mechanism. Curr Biol 17:
2175–2182.
42. Tanaka TU, Rachidi N, Janke C, Pereira G, Galova M, et al. (2002) Evidence
that the Ipl1-Sli15 (Aurora kinase-INCENP) complex promotes chromosome bi-
orientation by altering kinetochore-spindle pole connections. Cell 108: 317–329.
43. Alabed YZ, Pool M, Ong Tone S, Sutherland C, Fournier AE (2010) GSK3beta
regulates myelin-dependent axon outgrowth inhibition through CRMP4.
J Neurosci 30: 5635–5643.
44. Lovestone S, Hartley CL, Pearce J, Anderton BH (1996) Phosphorylation of tau
by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the
organization and stability of microtubules. Neuroscience 73: 1145–1157.
45. Akhmanova A, Hoogenraad CC, Drabek K, Stepanova T, Dortland B, et al.
(2001) Clasps are CLIP-115 and -170 associating proteins involved in the
regional regulation of microtubule dynamics in motile fibroblasts. Cell 104:
923–935.
46. Kaplan KB, Burds AA, Swedlow JR, Bekir SS, Sorger PK, et al. (2001) A role
for the Adenomatous Polyposis Coli protein in chromosome segregation. Nat
Cell Biol 3: 429–432.
47. Watanabe T, Noritake J, Kakeno M, Matsui T, Harada T, et al. (2009)
Phosphorylation of CLASP2 by GSK-3{beta} regulates its interaction with
IQGAP1, EB1 and microtubules. Journal of Cell Science 122: 2969–2979.
48. Meraldi P, Honda R, Nigg EA (2004) Aurora kinases link chromosome
segregation and cell division to cancer susceptibility. Curr Opin Genet Dev 14:
29–36.
49. Marumoto T, Zhang D, Saya H (2005) Aurora-A - a guardian of poles. Nat Rev
Cancer 5: 42–50.
50. Fumoto K, Lee PC, Saya H, Kikuchi A (2008) AIP regulates stability of Aurora-
A at early mitotic phase coordinately with GSK-3beta. Oncogene 27:
4478–4487.
51. Diehl JA, Cheng M, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase-
3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:
3499–3511.
52. Massague ´ J (2004) G1 cell-cycle control and cancer. Nature 432: 298–306.
53. Pizarro JG, Folch J, Esparza JL, Jordan J, Palla `s M, et al. (2008) A molecular
study of pathways involved in the inhibition of cell proliferation in
neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286.
J Cell Mol Med.
54. Yu ¨ce O, Piekny A, Glotzer M (2005) An ECT2-centralspindlin complex
regulates the localization and function of RhoA. The Journal of Cell Biology
170: 571–582.
55. Minturn JE, Geschwind DH, Fryer HJ, Hockfield S (1995) Early postmitotic
neurons transiently express TOAD-64, a neural specific protein. J Comp Neurol
355: 369–379.
GSK3 and Chromosome Alignment
PLoS ONE | www.plosone.org 15 December 2010 | Volume 5 | Issue 12 | e14345